Analyst consensus rating
West Pharmaceutical Services Analyst Rating: none
WST is rated none by 15 analysts with a $404.73 target. As of 2026-08-28.
Direct answer
West Pharmaceutical Services's consensus rating is none.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $404.73.
Forecast evidence checked August 28, 2026.
Get free West Pharmaceutical Services email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $346.09
- Average price target
- $404.73
- High price target
- $459.00
- Low price target
- $340.00
- Low target gap
- -1.8%
- Target upside
- +16.9%
- High target gap
- +32.6%
- Target range width
- 34.4%
- Consensus rating
- none
- Analysts
- 15
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for West Pharmaceutical Services?
West Pharmaceutical Services has a verified none consensus. The same dataset has an average price target of $404.73.
How far are West Pharmaceutical Services's low and high targets from the recorded price?
The low target implies -1.8%, while the high target implies +32.6%.
How many analysts are included in West Pharmaceutical Services's consensus?
The verified consensus includes 15 analysts.
How is West Pharmaceutical Services's target upside or downside calculated?
The average target of $404.73 is divided by the recorded price of $346.09, then one is subtracted to produce +16.9%. This does not guarantee a future return.
When was West Pharmaceutical Services's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.